Investors in Biotech And Medtech

Vinci is a subsidiary of Bank Gospodarstwa Krajowego. Its business is to manage alternative investment companies that provide appropriate solutions in the field of financing Polish entrepreneurs. Our goal is to retain ownership of innovative technologies and patents in Poland and to commercialize them in Poland and abroad. Vinci SA manages three funds: HiTech ASI, which provides capital to technology companies at various levels of development, Da Gama ASI, which finances the internationalization processes of Polish enterprises, and IQ ASI, which invests in research and scientific projects at early stages of development.

MedVenture is a venture capital fund investing in MedTech projects in the area of research and development with global potential. The fund's investment budget is PLN 40 million. MedVenture offers extensive smart money support for teams, including know-how, relationships and partnerships in the MedTech area as well as in the areas of IT, international marketing, law, finance, research, development and global scaling.

By investing capital, we put our knowledge and heart into all our projects. The team of experts of the Scanderia Venture fund consists of several dozens years of experience gathered in business practice, which now support the creators of ideas in which we believe. Everyone, even the best businesses, have been beginners at some point and we know that it is not easy to start. On the way from idea to product, we can meet at the idea stage, because our specialty is supporting projects at an early stage. Together with innovators, we develop, improve and introduce them to the market.